Global Meningococcal Vaccine Market Research Report 2026(Status and Outlook)
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.
The global Meningococcal Vaccine market size was estimated at USD 285.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Meningococcal Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Meningococcal Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Meningococcal Vaccine market.
Global Meningococcal Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market Segmentation (by Type)
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Market Segmentation (by Application)
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Vaccine Market
Overview of the regional outlook of the Meningococcal Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Meningococcal Vaccine market size was estimated at USD 285.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Meningococcal Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Meningococcal Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Meningococcal Vaccine market.
Global Meningococcal Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market Segmentation (by Type)
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Market Segmentation (by Application)
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Meningococcal Vaccine Market
Overview of the regional outlook of the Meningococcal Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Meningococcal Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Vaccine Segment by Type
1.2.2 Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Meningococcal Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Meningococcal Vaccine Product Life Cycle
3.3 Global Meningococcal Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Meningococcal Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Meningococcal Vaccine Market Competitive Situation and Trends
3.8.1 Meningococcal Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Meningococcal Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Meningococcal Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Meningococcal Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Meningococcal Vaccine Market Size by Type (2020-2025)
6.4 Global Meningococcal Vaccine Price by Type (2020-2025)
7 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccine Market Sales by Application (2020-2025)
7.3 Global Meningococcal Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
8 MENINGOCOCCAL VACCINE MARKET SALES BY REGION
8.1 Global Meningococcal Vaccine Sales by Region
8.1.1 Global Meningococcal Vaccine Sales by Region
8.1.2 Global Meningococcal Vaccine Sales Market Share by Region
8.2 Global Meningococcal Vaccine Market Size by Region
8.2.1 Global Meningococcal Vaccine Market Size by Region
8.2.2 Global Meningococcal Vaccine Market Size by Region
8.3 North America
8.3.1 North America Meningococcal Vaccine Sales by Country
8.3.2 North America Meningococcal Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Meningococcal Vaccine Sales by Country
8.4.2 Europe Meningococcal Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Meningococcal Vaccine Sales by Region
8.5.2 Asia Pacific Meningococcal Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Meningococcal Vaccine Sales by Country
8.6.2 South America Meningococcal Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Meningococcal Vaccine Sales by Region
8.7.2 Middle East and Africa Meningococcal Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MENINGOCOCCAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Meningococcal Vaccine by Region(2020-2025)
9.2 Global Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Meningococcal Vaccine Production
9.4.1 North America Meningococcal Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Meningococcal Vaccine Production
9.5.1 Europe Meningococcal Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Meningococcal Vaccine Production (2020-2025)
9.6.1 Japan Meningococcal Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Meningococcal Vaccine Production (2020-2025)
9.7.1 China Meningococcal Vaccine Production Growth Rate (2020-2025)
9.7.2 China Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Meningococcal Vaccine Product Overview
10.1.3 Novartis Meningococcal Vaccine Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Meningococcal Vaccine Product Overview
10.2.3 GSK Meningococcal Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck Meningococcal Vaccine Product Overview
10.3.3 Merck Meningococcal Vaccine Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 CSL
10.4.1 CSL Basic Information
10.4.2 CSL Meningococcal Vaccine Product Overview
10.4.3 CSL Meningococcal Vaccine Product Market Performance
10.4.4 CSL Business Overview
10.4.5 CSL Recent Developments
10.5 Baxter
10.5.1 Baxter Basic Information
10.5.2 Baxter Meningococcal Vaccine Product Overview
10.5.3 Baxter Meningococcal Vaccine Product Market Performance
10.5.4 Baxter Business Overview
10.5.5 Baxter Recent Developments
10.6 JN International Medical Corporation
10.6.1 JN International Medical Corporation Basic Information
10.6.2 JN International Medical Corporation Meningococcal Vaccine Product Overview
10.6.3 JN International Medical Corporation Meningococcal Vaccine Product Market Performance
10.6.4 JN International Medical Corporation Business Overview
10.6.5 JN International Medical Corporation Recent Developments
10.7 Serum Institute of India
10.7.1 Serum Institute of India Basic Information
10.7.2 Serum Institute of India Meningococcal Vaccine Product Overview
10.7.3 Serum Institute of India Meningococcal Vaccine Product Market Performance
10.7.4 Serum Institute of India Business Overview
10.7.5 Serum Institute of India Recent Developments
10.8 Bio-Med
10.8.1 Bio-Med Basic Information
10.8.2 Bio-Med Meningococcal Vaccine Product Overview
10.8.3 Bio-Med Meningococcal Vaccine Product Market Performance
10.8.4 Bio-Med Business Overview
10.8.5 Bio-Med Recent Developments
10.9 China National Biotec Group
10.9.1 China National Biotec Group Basic Information
10.9.2 China National Biotec Group Meningococcal Vaccine Product Overview
10.9.3 China National Biotec Group Meningococcal Vaccine Product Market Performance
10.9.4 China National Biotec Group Business Overview
10.9.5 China National Biotec Group Recent Developments
10.10 Hualan Bio
10.10.1 Hualan Bio Basic Information
10.10.2 Hualan Bio Meningococcal Vaccine Product Overview
10.10.3 Hualan Bio Meningococcal Vaccine Product Market Performance
10.10.4 Hualan Bio Business Overview
10.10.5 Hualan Bio Recent Developments
10.11 Walvax
10.11.1 Walvax Basic Information
10.11.2 Walvax Meningococcal Vaccine Product Overview
10.11.3 Walvax Meningococcal Vaccine Product Market Performance
10.11.4 Walvax Business Overview
10.11.5 Walvax Recent Developments
10.12 Zhifei
10.12.1 Zhifei Basic Information
10.12.2 Zhifei Meningococcal Vaccine Product Overview
10.12.3 Zhifei Meningococcal Vaccine Product Market Performance
10.12.4 Zhifei Business Overview
10.12.5 Zhifei Recent Developments
11 MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
11.1 Global Meningococcal Vaccine Market Size Forecast
11.2 Global Meningococcal Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Vaccine Market Size Forecast by Region
11.2.4 South America Meningococcal Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Meningococcal Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Meningococcal Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Meningococcal Vaccine by Type (2026-2035)
12.1.2 Global Meningococcal Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Meningococcal Vaccine by Type (2026-2035)
12.2 Global Meningococcal Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Meningococcal Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Meningococcal Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Vaccine Segment by Type
1.2.2 Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Meningococcal Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Meningococcal Vaccine Product Life Cycle
3.3 Global Meningococcal Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Meningococcal Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Meningococcal Vaccine Market Competitive Situation and Trends
3.8.1 Meningococcal Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Meningococcal Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Meningococcal Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Meningococcal Vaccine Market
5.7 ESG Ratings of Leading Companies
6 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Meningococcal Vaccine Market Size by Type (2020-2025)
6.4 Global Meningococcal Vaccine Price by Type (2020-2025)
7 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccine Market Sales by Application (2020-2025)
7.3 Global Meningococcal Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
8 MENINGOCOCCAL VACCINE MARKET SALES BY REGION
8.1 Global Meningococcal Vaccine Sales by Region
8.1.1 Global Meningococcal Vaccine Sales by Region
8.1.2 Global Meningococcal Vaccine Sales Market Share by Region
8.2 Global Meningococcal Vaccine Market Size by Region
8.2.1 Global Meningococcal Vaccine Market Size by Region
8.2.2 Global Meningococcal Vaccine Market Size by Region
8.3 North America
8.3.1 North America Meningococcal Vaccine Sales by Country
8.3.2 North America Meningococcal Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Meningococcal Vaccine Sales by Country
8.4.2 Europe Meningococcal Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Meningococcal Vaccine Sales by Region
8.5.2 Asia Pacific Meningococcal Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Meningococcal Vaccine Sales by Country
8.6.2 South America Meningococcal Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Meningococcal Vaccine Sales by Region
8.7.2 Middle East and Africa Meningococcal Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MENINGOCOCCAL VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Meningococcal Vaccine by Region(2020-2025)
9.2 Global Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Meningococcal Vaccine Production
9.4.1 North America Meningococcal Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Meningococcal Vaccine Production
9.5.1 Europe Meningococcal Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Meningococcal Vaccine Production (2020-2025)
9.6.1 Japan Meningococcal Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Meningococcal Vaccine Production (2020-2025)
9.7.1 China Meningococcal Vaccine Production Growth Rate (2020-2025)
9.7.2 China Meningococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Meningococcal Vaccine Product Overview
10.1.3 Novartis Meningococcal Vaccine Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 GSK
10.2.1 GSK Basic Information
10.2.2 GSK Meningococcal Vaccine Product Overview
10.2.3 GSK Meningococcal Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Merck
10.3.1 Merck Basic Information
10.3.2 Merck Meningococcal Vaccine Product Overview
10.3.3 Merck Meningococcal Vaccine Product Market Performance
10.3.4 Merck Business Overview
10.3.5 Merck SWOT Analysis
10.3.6 Merck Recent Developments
10.4 CSL
10.4.1 CSL Basic Information
10.4.2 CSL Meningococcal Vaccine Product Overview
10.4.3 CSL Meningococcal Vaccine Product Market Performance
10.4.4 CSL Business Overview
10.4.5 CSL Recent Developments
10.5 Baxter
10.5.1 Baxter Basic Information
10.5.2 Baxter Meningococcal Vaccine Product Overview
10.5.3 Baxter Meningococcal Vaccine Product Market Performance
10.5.4 Baxter Business Overview
10.5.5 Baxter Recent Developments
10.6 JN International Medical Corporation
10.6.1 JN International Medical Corporation Basic Information
10.6.2 JN International Medical Corporation Meningococcal Vaccine Product Overview
10.6.3 JN International Medical Corporation Meningococcal Vaccine Product Market Performance
10.6.4 JN International Medical Corporation Business Overview
10.6.5 JN International Medical Corporation Recent Developments
10.7 Serum Institute of India
10.7.1 Serum Institute of India Basic Information
10.7.2 Serum Institute of India Meningococcal Vaccine Product Overview
10.7.3 Serum Institute of India Meningococcal Vaccine Product Market Performance
10.7.4 Serum Institute of India Business Overview
10.7.5 Serum Institute of India Recent Developments
10.8 Bio-Med
10.8.1 Bio-Med Basic Information
10.8.2 Bio-Med Meningococcal Vaccine Product Overview
10.8.3 Bio-Med Meningococcal Vaccine Product Market Performance
10.8.4 Bio-Med Business Overview
10.8.5 Bio-Med Recent Developments
10.9 China National Biotec Group
10.9.1 China National Biotec Group Basic Information
10.9.2 China National Biotec Group Meningococcal Vaccine Product Overview
10.9.3 China National Biotec Group Meningococcal Vaccine Product Market Performance
10.9.4 China National Biotec Group Business Overview
10.9.5 China National Biotec Group Recent Developments
10.10 Hualan Bio
10.10.1 Hualan Bio Basic Information
10.10.2 Hualan Bio Meningococcal Vaccine Product Overview
10.10.3 Hualan Bio Meningococcal Vaccine Product Market Performance
10.10.4 Hualan Bio Business Overview
10.10.5 Hualan Bio Recent Developments
10.11 Walvax
10.11.1 Walvax Basic Information
10.11.2 Walvax Meningococcal Vaccine Product Overview
10.11.3 Walvax Meningococcal Vaccine Product Market Performance
10.11.4 Walvax Business Overview
10.11.5 Walvax Recent Developments
10.12 Zhifei
10.12.1 Zhifei Basic Information
10.12.2 Zhifei Meningococcal Vaccine Product Overview
10.12.3 Zhifei Meningococcal Vaccine Product Market Performance
10.12.4 Zhifei Business Overview
10.12.5 Zhifei Recent Developments
11 MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
11.1 Global Meningococcal Vaccine Market Size Forecast
11.2 Global Meningococcal Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Meningococcal Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Meningococcal Vaccine Market Size Forecast by Region
11.2.4 South America Meningococcal Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Meningococcal Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Meningococcal Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Meningococcal Vaccine by Type (2026-2035)
12.1.2 Global Meningococcal Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Meningococcal Vaccine by Type (2026-2035)
12.2 Global Meningococcal Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Meningococcal Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Meningococcal Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Meningococcal Vaccine Market Size by Type (M USD)
Table 4. Global Meningococcal Vaccine Market Size by Application
Table 5. Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Meningococcal Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Meningococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Meningococcal Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Meningococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2025)
Table 11. Global Market Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Meningococcal Vaccine Sales by Type (K MT)
Table 27. Global Meningococcal Vaccine Market Size by Type (M USD)
Table 28. Global Meningococcal Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Meningococcal Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Meningococcal Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Meningococcal Vaccine Market Share by Type (2020-2025)
Table 32. Global Meningococcal Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Meningococcal Vaccine Sales (K MT) by Application
Table 34. Global Meningococcal Vaccine Market Size by Application
Table 35. Global Meningococcal Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Meningococcal Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Meningococcal Vaccine Market Share by Application (2020-2025)
Table 39. Global Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Meningococcal Vaccine Market Size by Region (2020-2025)
Table 44. North America Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Meningococcal Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Meningococcal Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Meningococcal Vaccine Product Overview
Table 64. Novartis Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Meningococcal Vaccine Product Overview
Table 70. GSK Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Merck Basic Information
Table 75. Merck Meningococcal Vaccine Product Overview
Table 76. Merck Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. CSL Basic Information
Table 81. CSL Meningococcal Vaccine Product Overview
Table 82. CSL Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CSL Business Overview
Table 84. CSL Recent Developments
Table 85. Baxter Basic Information
Table 86. Baxter Meningococcal Vaccine Product Overview
Table 87. Baxter Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Baxter Business Overview
Table 89. Baxter Recent Developments
Table 90. JN International Medical Corporation Basic Information
Table 91. JN International Medical Corporation Meningococcal Vaccine Product Overview
Table 92. JN International Medical Corporation Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. JN International Medical Corporation Business Overview
Table 94. JN International Medical Corporation Recent Developments
Table 95. Serum Institute of India Basic Information
Table 96. Serum Institute of India Meningococcal Vaccine Product Overview
Table 97. Serum Institute of India Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Serum Institute of India Business Overview
Table 99. Serum Institute of India Recent Developments
Table 100. Bio-Med Basic Information
Table 101. Bio-Med Meningococcal Vaccine Product Overview
Table 102. Bio-Med Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Med Business Overview
Table 104. Bio-Med Recent Developments
Table 105. China National Biotec Group Basic Information
Table 106. China National Biotec Group Meningococcal Vaccine Product Overview
Table 107. China National Biotec Group Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. China National Biotec Group Business Overview
Table 109. China National Biotec Group Recent Developments
Table 110. Hualan Bio Basic Information
Table 111. Hualan Bio Meningococcal Vaccine Product Overview
Table 112. Hualan Bio Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Hualan Bio Business Overview
Table 114. Hualan Bio Recent Developments
Table 115. Walvax Basic Information
Table 116. Walvax Meningococcal Vaccine Product Overview
Table 117. Walvax Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Walvax Business Overview
Table 119. Walvax Recent Developments
Table 120. Zhifei Basic Information
Table 121. Zhifei Meningococcal Vaccine Product Overview
Table 122. Zhifei Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Zhifei Business Overview
Table 124. Zhifei Recent Developments
Table 125. Global Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Meningococcal Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Meningococcal Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Meningococcal Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Meningococcal Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Meningococcal Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Meningococcal Vaccine Market Size by Type (M USD)
Table 4. Global Meningococcal Vaccine Market Size by Application
Table 5. Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Meningococcal Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Meningococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Meningococcal Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Meningococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2025)
Table 11. Global Market Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Meningococcal Vaccine Sales by Type (K MT)
Table 27. Global Meningococcal Vaccine Market Size by Type (M USD)
Table 28. Global Meningococcal Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Meningococcal Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Meningococcal Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Meningococcal Vaccine Market Share by Type (2020-2025)
Table 32. Global Meningococcal Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Meningococcal Vaccine Sales (K MT) by Application
Table 34. Global Meningococcal Vaccine Market Size by Application
Table 35. Global Meningococcal Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Meningococcal Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Meningococcal Vaccine Market Share by Application (2020-2025)
Table 39. Global Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Meningococcal Vaccine Market Size by Region (2020-2025)
Table 44. North America Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Meningococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Meningococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Meningococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Meningococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Meningococcal Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Meningococcal Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Meningococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Meningococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Meningococcal Vaccine Product Overview
Table 64. Novartis Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. GSK Basic Information
Table 69. GSK Meningococcal Vaccine Product Overview
Table 70. GSK Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GSK Business Overview
Table 72. GSK SWOT Analysis
Table 73. GSK Recent Developments
Table 74. Merck Basic Information
Table 75. Merck Meningococcal Vaccine Product Overview
Table 76. Merck Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Merck Business Overview
Table 78. Merck SWOT Analysis
Table 79. Merck Recent Developments
Table 80. CSL Basic Information
Table 81. CSL Meningococcal Vaccine Product Overview
Table 82. CSL Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CSL Business Overview
Table 84. CSL Recent Developments
Table 85. Baxter Basic Information
Table 86. Baxter Meningococcal Vaccine Product Overview
Table 87. Baxter Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Baxter Business Overview
Table 89. Baxter Recent Developments
Table 90. JN International Medical Corporation Basic Information
Table 91. JN International Medical Corporation Meningococcal Vaccine Product Overview
Table 92. JN International Medical Corporation Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. JN International Medical Corporation Business Overview
Table 94. JN International Medical Corporation Recent Developments
Table 95. Serum Institute of India Basic Information
Table 96. Serum Institute of India Meningococcal Vaccine Product Overview
Table 97. Serum Institute of India Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Serum Institute of India Business Overview
Table 99. Serum Institute of India Recent Developments
Table 100. Bio-Med Basic Information
Table 101. Bio-Med Meningococcal Vaccine Product Overview
Table 102. Bio-Med Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Med Business Overview
Table 104. Bio-Med Recent Developments
Table 105. China National Biotec Group Basic Information
Table 106. China National Biotec Group Meningococcal Vaccine Product Overview
Table 107. China National Biotec Group Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. China National Biotec Group Business Overview
Table 109. China National Biotec Group Recent Developments
Table 110. Hualan Bio Basic Information
Table 111. Hualan Bio Meningococcal Vaccine Product Overview
Table 112. Hualan Bio Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Hualan Bio Business Overview
Table 114. Hualan Bio Recent Developments
Table 115. Walvax Basic Information
Table 116. Walvax Meningococcal Vaccine Product Overview
Table 117. Walvax Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Walvax Business Overview
Table 119. Walvax Recent Developments
Table 120. Zhifei Basic Information
Table 121. Zhifei Meningococcal Vaccine Product Overview
Table 122. Zhifei Meningococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Zhifei Business Overview
Table 124. Zhifei Recent Developments
Table 125. Global Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Meningococcal Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Meningococcal Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Meningococcal Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Meningococcal Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Meningococcal Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Meningococcal Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Meningococcal Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Meningococcal Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Meningococcal Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Meningococcal Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Meningococcal Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Meningococcal Vaccine Product Life Cycle
Figure 13. Meningococcal Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Meningococcal Vaccine
Figure 19. Global Meningococcal Vaccine Market PEST Analysis
Figure 20. Global Meningococcal Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Meningococcal Vaccine Market Share by Type
Figure 27. Sales Market Share of Meningococcal Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Meningococcal Vaccine by Type in 2025
Figure 29. Market Share of Meningococcal Vaccine by Type (2020-2025)
Figure 30. Market Share of Meningococcal Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Meningococcal Vaccine Market Share by Application
Figure 33. Global Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Meningococcal Vaccine Sales Market Share by Application in 2025
Figure 35. Global Meningococcal Vaccine Market Share by Application (2020-2025)
Figure 36. Global Meningococcal Vaccine Market Share by Application in 2025
Figure 37. Global Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Meningococcal Vaccine Market Size by Region (2020-2025)
Figure 40. North America Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 43. North America Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Meningococcal Vaccine Market Size by Country in 2024
Figure 45. U.S. Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Meningococcal Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Meningococcal Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Meningococcal Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Meningococcal Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Meningococcal Vaccine Market Size by Country in 2024
Figure 55. Germany Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Meningococcal Vaccine Market Size by Region in 2024
Figure 68. China Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 80. South America Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Meningococcal Vaccine Market Size by Country in 2024
Figure 82. Brazil Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Meningococcal Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Meningococcal Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Meningococcal Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Meningococcal Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Meningococcal Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Meningococcal Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Meningococcal Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Meningococcal Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Meningococcal Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Meningococcal Vaccine Product Life Cycle
Figure 13. Meningococcal Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Meningococcal Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Meningococcal Vaccine
Figure 19. Global Meningococcal Vaccine Market PEST Analysis
Figure 20. Global Meningococcal Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Meningococcal Vaccine Market Share by Type
Figure 27. Sales Market Share of Meningococcal Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Meningococcal Vaccine by Type in 2025
Figure 29. Market Share of Meningococcal Vaccine by Type (2020-2025)
Figure 30. Market Share of Meningococcal Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Meningococcal Vaccine Market Share by Application
Figure 33. Global Meningococcal Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Meningococcal Vaccine Sales Market Share by Application in 2025
Figure 35. Global Meningococcal Vaccine Market Share by Application (2020-2025)
Figure 36. Global Meningococcal Vaccine Market Share by Application in 2025
Figure 37. Global Meningococcal Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Meningococcal Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Meningococcal Vaccine Market Size by Region (2020-2025)
Figure 40. North America Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 43. North America Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Meningococcal Vaccine Market Size by Country in 2024
Figure 45. U.S. Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Meningococcal Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Meningococcal Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Meningococcal Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Meningococcal Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Meningococcal Vaccine Market Size by Country in 2024
Figure 55. Germany Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Meningococcal Vaccine Market Size by Region in 2024
Figure 68. China Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Meningococcal Vaccine Sales Market Share by Country in 2024
Figure 80. South America Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Meningococcal Vaccine Market Size by Country in 2024
Figure 82. Brazil Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Meningococcal Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Meningococcal Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Meningococcal Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Meningococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Meningococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Meningococcal Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Meningococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Meningococcal Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Meningococcal Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Meningococcal Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Meningococcal Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Meningococcal Vaccine Market Share Forecast by Application (2026-2035)
